A company still losing money with shrinking sales, with elevated risk.
Facts from SEC filings, not a recommendation.
Last 12 months: $27.9M.
Price chart by TradingView.
From annual reports filed with the SEC. Gross margin doesn't apply to banks and insurers, so it isn't scored. Not in this company's SEC data, so not scored: profitable every year, share count not growing. A checklist is a starting point for research, not a verdict.
No open-market insider buys or sells in the last 90 days.
No trades to chart yet.
SEC filings of any kind. 50 means a normal week.
Institutions held almost none of it the quarter before (new listing, spin-off or ticker change), so there's no fair percent change yet. 34 bought, 0 sold.
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
17,841,993 shares
108,200,628 shares
10,623 shares
42,492 shares
70,821 shares
10,623 shares
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page